Services on Demand
On-line version ISSN 1678-9946
Rev. Inst. Med. trop. S. Paulo vol.50 no.3 São Paulo May/June 2008 Epub May 14, 2008
Identificação genotípica de Cryptosporidium spp. isolados a partir de pacientes com HIV e crianças imunocompetentes de São Paulo, Brasil
Ana Julia Urias dos Santos AraújoI,II; Herminia Yohko KanamuraI,II; Marcos Eduardo de AlmeidaI; Aparecida Helena de Souza GomesIII; Thais Helena Lemos PintoIV; Alexandre Januário Da SilvaV
IInstituto Básico de Biociências, Universidade de Taubaté, Taubaté, SP, Brasil
IIFaculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP, Brasil
IIIInstituto Adolfo Lutz, Sorocaba, SP, Brasil
IVHospital Albert Einsten, São Paulo, SP, Brasil
VCenters for Disease Control and Prevention, Atlanta, GA, USA
Cryptosporidium isolates identified in fourteen stool samples, collected from five HIV-infected patients and nine immunocompetent children, living in the Sate of São Paulo, Brazil, were submitted to a molecular analysis using a nested PCR followed of restriction fragment length polymorphism (RFLP), for genetic characterization. The analysis was based on digestion with RsaI restriction enzyme of a DNA fragment amplified from the Cryptosporidium oocyst wall protein (COWP) gene. Based on this analysis, four samples were identified as Cryptosporidium parvum, eight as Cryptosporidium hominis and two presented a profile that correspondedto Cryptosporidium meleagridis when compared to the standards used in the analysis. The use of molecular methods can be helpful to identify source of infections and risk factors related to Cryptosporidium infection in our communities.
Keywords: Cryptosporidiosis; PCR; Genotyping; Cryptosporidium parvum; Cryptosporidium hominis;Cryptosporidium meleagridis; Brazil.
Isolados de Cryptosporidium identificados em quatorze amostras de fezes, coletadas de cinco pacientes com infecção por HIV e de nove crianças imunocompetentes, residentes no estado de São Paulo, Brasil, foram submetidos a análise molecular por Nested-PCR, seguido da caracterização genética por polimorfismo do tamanho do fragmento de restrição (RFLP). A análise foi baseada na digestão, com a enzima de restrição RsaI, de um fragmento de DNA amplificado do gene que codifica a proteína de parede do oocisto de Cryptosporidium (COWP). Baseado nesta análise, quando comparadas aos padrões utilizados, quatro amostras foram identificadas como Cryptosporidium parvum, oito como Cryptosporidium hominis e duas apresentaram um perfil correspondente ao de Cryptosporidium meleagridis. O uso de métodos moleculares pode ser útil para identificar a fonte das infecções e os fatores de risco relacionados à infecção por Cryptosporidium em nossas comunidades.
Nearly 100 years after description of the first Cryptosporidium species, in mice by Tyzzer, it is known that Cryptosporidium spp. can occur in distinct classes of vertebrates, such as fishes, reptiles, amphibians, birds and mammals12,20, 27,28.
In humans, infection by Cryptosporidium sp. was first registered in 1976, and Cryptosporidium parvum (previously known as cattle genotype orgenotype 2) and Cryptosporidium hominis (previously known as C. parvum - human genotype or genotype 1) have been recorded as the two species most frequent cause of human cryptosporidiosis, either associated with sporadic cases of infections or outbreaks, some of them being very large as the one that occurred in Milwaukee WI, USA, which affected approximately 400,000 persons12,17. To date, all the cryptosporidiosis outbreaks occurring worldwide have been caused by C. hominis and C. parvum, with several being associated with consumption of drinking water or exposure to recreational water contaminated with Cryptosporidium oocysts of zoonotic and anthroponotic origins15,27,30.Due to the size and frequency of these outbreaks, cryptosporidiosis became a serious public health issue worldwide and prompted reevaluation of the microbiological standards for drinking water by health authorities in developed and developing countries. In countries like Brazil, it is mandatory that potable water be also free of Cryptosporidium sp. and Giardia sp.3.
Although all outbreaks studied to date have been associated with the two species of Cryptosporidium listed above, it is also known that at least some zoonotic species, such as Cryptosporidium canis, Cryptosporidium felis, and Cryptosporidium meleagridis, can indeed infect both immunocompromised and immunocompetent persons4,14,18,21,22,24.
In different regions of Brazil, including São Paulo, studies involving patients with compromised immune systems either HIV-positive or not, and children, with or without diarrhea, have shown different rates for presence of Cryptosporidium spp. in their stools5,7,8,15,19,25. Serological surveys conducted in Brazil showed the presence of anti-Cryptosporidium antibodies in a large number of children living in slums of the northeastern region of Fortaleza, state of Ceara1, and also in individuals with no intestinal symptoms living in the state of Sao Paulo. In this last study the frequencies for anti-Cryptosporidium antibodies varied from 10% to 80%, according to the age group9. Environmental contamination with Cryptosporidium was also reported in rivers and other public water sources11,13. Despite the great number of reports about occurrence of Cryptosporidium infection in Brazil, only few studies addressed the molecular characterization of the isolates found in the studied clinical specimens. In one of the studies carried out in the northeast region, two isolates were identified as C. parvum, one as C. hominis, but the authors were not able to genetically characterized one of the isolates2. Another study identified seven Brazilian children infected with C. hominis14 and another revealed the presence of a single genotype of C. hominis based on analysis of three genes in 29 samples from a diarrhea outbreak investigated in a day care in São Paulo, SP15.
In the present study, a nested PCR followed by RFLP, of a fragment of the Cryptosporidium oocyst wall protein (COWP) gene, was used to identify the species of Cryptosporidium isolates from HIV-infected patients and immunocompetent children living in the Sate of São Paulo, Brazil.
MATERIAL AND METHODS
Cryptosporidium isolates. A total of 14 stool samples, positive for Cryptosporidium sp. by microscopic examination of stools, were obtained from adults and children, with or without diarrhea, living in three cities of the State of Sao Paulo, Brazil. Five samples (SO32, SO49, SO507, SO623 and SO689) were obtained from HIV-infected patients submitted to diagnostic testing at the Public Health Laboratory of Sorocaba city; five samples (SP06, SP07, SP12, SP17 and SP31) were obtained from children living in a slum located in the city of São Paulo and submitted for testing by the Parasitology Laboratory of the Albert Einstein Hospital; and four samples (TT01, TT03, TT06 and TT07) were selected during an active laboratory survey focusing on identification of cases of cryptosporidiosis in day care center from the city of Taubate, São Paulo State. The aspect of the childrens stool samples varied from formed (n = 6) to loose-diarrheic (n = 3) and they were included in the study after identification of Cryptosporidium oocysts by Kinyoun staining methodor detection of Cryptosporidium antigens by ELISA test on micro plate (ProSpecT - Alexon Inc.). The study protocol was approved by the Research Ethical Committee of the University of Taubate.
DNA extraction. DNA was extracted from stool samples using the FastDNA® method (MP Biomedicals, Solon, OH), as previously described10 with the exception that the samples were disrupted using vortex mixer, instead of the FP120 FastPrep cell disrupter. For disruption, samples were agitated by vortexing during one minute three consecutive times. The extracted DNA was further purified with the QIAquick PCR purification kit (Qiagen, Inc., Santa Clarita, CA), according to manufacturers instructions, for complete removing of the PCR inhibitors10, and then stored at -20 ºC.
Amplification of fragments from the COWP gene. Nested-PCR was carried out using the protocol described by PEDRAZA-DIAZ et al.23: in the first step amplification, primers BCOWPF (ACC GCT TCT CAA CAA CCA TCT TGT CCT C) and BCOWPR (CGC ACC TGT TCC CAC TCA ATG TAA ACC C) were used to produce a fragment of 769-bp; in the secondary PCR, primers Cry15 (GTA GAT AAT GGA AGA GAT TGT G) and Cry9 (GGA CTG AAA TAC AGG CAT TAT CTT G), described by SPANO et al.26, were used to amplify a DNA fragment of 553-bp. PCR reactions were performed in a total volume of 25 µL containing 2.5 µL of the DNA template in 1x PCR buffer, 1.5 mM MgCl2, 0.25 mM of each dNTP (Amersham Bioscences), 10 pmoles of each primer, and 1.25 units of Taq DNA polymerase (Invitrogen, Brazil). Cycling conditions used were: initial denaturation cycle of 94 ºC for fivee minutes, followed by 30 cycles of 65 ºC for one minute, 72 ºC for one minute and 94 º C for one minute; and a final extension at 72 ºC for 10 minutes, which were carried out in a Mastercycle Gradient (Eppendorf, Hamburg, Germany). 2.5 uL of the products of the primary PCR were amplified with Cry15/Cry9 primers using the same volumes, concentrations of reagents and themocycler listed above. Cycling conditions for the nested PCR were: initial denaturation of 94 ºC for five minutes, followed by 30 cycles of 55 ºC for 30 seconds, 72 ºC for 50 seconds and 94 º C for 50 seconds, and a final extension at 72 ºC for 10 minutes. The PCR products were analyzed by electrophoresis on 1.5% agarose gel, stained with ethidium bromide, visualized on an ultraviolet transilluminator, and then digitalized (Digital Kodak Science 1DTM).
RFLP analysis. An aliquot of 5µL of each nested-PCR product was subjected to digestion with RsaI restriction enzyme (Amersham Biosciences), for 12 hs at 37 ºC, according to manufacturer´s protocol. Restriction products were separated through electrophoresis on a 3.0% agarose gel, visualized by staining with ethidium bromide, followed by ultraviolet transillumination, and then digitalized (Digital Kodak Science 1DTM). Size markers included in all gels were 100bp DNA Ladder (Invitrogen, Brazil). The RFLP patterns of different Cryptosporidium isolates were compared to the sequences available in the GenBank.
Amplicons with the expected size were generated from 14 isolates using the COWP Nested-PCR. In order to characterize these amplicons, we used a standard RFLP protocol with RsaI restriction enzyme. Three distinct RFLP patterns were obtained, which indicated the presence of C. parvum,C. hominis, and C. meleagridis based on patterns that could be obtained with COWP gene sequences for these three species available in GenBank. Eight isolates revealed fragments of 284, 129, 106 and 34-bp which would indicate the presence of C. hominis, based on RsaI RFLP patterns with GenBAnk accession numbers: AF248741; AJ849458; AJ849459; AY282691; AJ971799; AJ971800 and AJ971801. Fragments of 413, 106 and 34-bp were obtained from four samples, and these were related to C. parvum based on the same rationale using GenBank accession numbers: AB89292; AF248743; AF266265; AF266273; AY277701; and Z22537. Fragments of 372, 147 and 34-bp were obtained from two samples, which would indicate the presence of C. meleagridis, based on GenBank accession numbers: AF248742; AF266266; AJ971802; AY166840; AY282694 and DQ116568. The distribution of the 14 Cryptosporidium isolates according to the identified species and the city of origin, Taubaté (TT), Sorocaba (SO) and São Paulo (SP), was presented in the Table 1. Representation of the sites of cleavage (GT?AC) found in the Cry15/Cry9 amplicons is showed in Fig. 1. A representative gel showing RFLP profiles of three genetic groups, detected in this study, is shown in Fig. 2.
The relevance of Cryptosporidium sp. as a causative agent of severe and chronic diarrhea, representing an important cause of morbidity and mortality among malnourished children and immunocompromised patients, such as those infected with HIV or submitted to organ transplants8,25,28, has been extensively discussed in the literature. However, the prevalence of this parasite in immunocompetent children is not well known. The morphologic diagnosis of this parasite is a challenge for microscopist unless they are very well trained in recognizing Cryptosporidium sp. oocysts in stool samples. This is enhanced by the fact that not all clinical laboratories in Brazil perform special staining techniques, eg, modified acid-fast recommended for the detection of Cryptosporidium sp. oocysts16. Also, in Brazil, it is not a practice among the pediatricians to request a specific laboratory diagnostic test for cryptosporidiosis in cases of diarrhea illness.
Among the 16 currently accepted species of Cryptosporidium27, C. hominis and C. parvum are the most frequently associated to human infections. However, zoonotic species, such as C. meleagridis,C. felis, and C. canis, and also other genotypes of C. parvum, adapted to varied animal species, have been isolated from patients with cryptosporidiosis and identified by molecular methods18,21,22,24,29,30. These findings bring up evidences that different species of Cryptosporidium can circulate in the environment, being potential pathogens for humans and animals; this justify the use of molecular techniques for characterization of Cryptosporidium at species level, for better understanding the epidemiology of cryptosporidiosis in specific areas.
The occurrence of the Cryptosporidium anthroponotic and the zoonotic transmission cycles overlapping in the same area enhances the exposure of human beings to this parasite, especially in areas with inadequate sanitary infrastructure. Consequently, contaminated water and foods can be important vehicles for transmission of cryptosporidiosis12. For obvious reasons, special attention must be given to water, considering that Cryptosporidium oocysts are resistant to chlorination. Thus, efforts to improve detection and identification of the parasite as well as disinfection of drinking and recreational water have been the focus of many public health programs worldwide. Nowadays it is important that the diagnosis of cryptosporidiosis must be carried out not only by morphologic criteria, but also by molecular techniques to allow accurate identification of Cryptosporidium at species level. Several species of this genus are morphologically indistinguishable and only microscopic examination is not enough for species identification in clinical or environment samples.
In the present study, the use of molecular tools allowed the identification of three different species of Cryptosporidium, i.e., C. hominis,C. parvum and C. meleagridis, the later being identified only in two HIV-infected patients. It is known that this species naturally infect different species of birds, and in humans it is more frequently described in HIV-infected patients, although different authors have identified cases of C. meleagridis infection not restricted to immunocompromised individuals6,22,29. Among the nine immunocompetent children studied, six cases were associated with infection by C. hominis and three cases by C. parvum.Although the number of samples studied was not large, the observation that more infections with C. hominis than C. parvum were detected may indicate the predominance of the anthroponotic cycle in the studied areas. This situation was more evident among the children living in a slum of the São Paulo City, where four samples were positive for C. hominis and only one was positive for C. parvum. It is also interesting to notice the identification of two cases of C. parvum and two of C. hominis among children in the day care in Taubaté City. It might suggest a possible occurrence of person-to-person transmission of some zoonotic species, after its introduction into confined environments, such as day-care-centers, home-care and hospital settings; and then, it might be able to present an anthroponotic standard of transmission, with a significant epidemiological implication on public health. The use of molecular tools in studies such as the one presented here will allow better characterization of Cryptosporidium species, which is helpful to identify the source of infections and risk factors, and to allow the control of cryptosporidiosis in our communities.
To FAPESP - Fundação de Amparo à Pesquisa do Estado de São Paulo - for the financial support (Proc. 00/13985-5).
1. AGNEW, D.G.; LIMA, A.A.; NEWMAN, R.D. et al. - Cryptosporidiosis in northeastern Brazilian children: association with increases diarrhea morbidity. J. infect. Dis., 177: 754-760, 1998. [ Links ]
2. BRANTLEY, R.K.; WILLIAMS, K.R.; SILVA, T.M.J. et al. - AIDS-associated diarrhoea and wasting in northeast Brazil is associated with subtherapeutic plasma levels of antiretroviral medications and with both bovine and human subtypes of Cryptosporidium parvum. Braz. J. infect. Dis., 7: 16-22, 2003. [ Links ]
3. BRASIL. Ministério da Saúde. Secretaria de Vigilância em Saúde. Coordenação-Geral de Vigilância em Saúde Ambiental - Portaria MS nº 518/2004.Brasília. Série E. Legislação de Saúde, 2004. [ Links ]
4. CAMA, V.A.; BERN, C.; SULAIMAN, I.M. et al. - Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J. eukaryot. Microbiol., 50 (suppl.): 531-533, 2003. [ Links ]
5. CARVALHO-ALMEIDA, T.T.; PINTO, P.L.S.; QUADROS, C.M.S. et al. - Detection of Cryptosporidium sp. in non diarrheal faeces from children, in a day care center in the city of São Paulo, Brazil. Rev. Inst. Med. trop. S. Paulo, 48: 27-32, 2006. [ Links ]
6. CHALMERS, R.M.; ELWIN, K.; THOMAS, A.L. & JOYNSON, D.H. - Infection with unusual types of Cryptosporidium is not restricted to immunocompromised patients. J. infect. Dis., 185: 270-271, 2002. [ Links ]
7. CHIEFFI, P.P.; PASCHOALOTTI, M.A.; VERGUEIRO, C.S. & CHIATTONE, C.S. - Infection by Cryptosporidium sp. in immunocompromised haematological patients. Rev. Inst. Med. trop. S. Paulo, 47: 301-302, 2005. [ Links ]
8. CIMERMAN, S.; CIMERMAN, B. & LEWI, D.S. - Prevalence of intestinal parasitic infections in patients with acquired immunodeficiency syndrome in Brazil. Int. J. infect. Dis., 3: 203-206, 1999. [ Links ]
9. COX, M.J.; ELWIN, K.; MASSAD, E. & AZEVEDO, R.S. - Age-specific seroprevalence to an immunodominant Cryptosporidium sporozoite antigen in a Brazilian population. Epidem. Infect., 133: 951-956, 2005. [ Links ]
10. DA SILVA, A.J.; BORNAY-LLINARES, F.J.; MOURA, I.N.S. et al. - Fast and reliable extraction of protozoan parasite DNA from fecal specimens. Mol. Diagn., 4: 57-64, 1999. [ Links ]
11. FARIAS, E.W.C.; GAMBA, R.C. & PELLIZARI, V.H. - Detection of Cryptosporidium spp. oocysts in raw sewage and creek water in the city of Sao Paulo, Brazil.Braz. J. Microbiol., 33: 41-43, 2002. [ Links ]
12. FAYER, R.; MORGAN, U. & UPTON, S.J. - Epidemiology of Cryptosporidium: transmission, detection and identification. Int. J. Parasit., 30: 1305-1322, 2000. [ Links ]
13. FRANCO, R.M.B.; ROCHA-EBERHARDT, R. & CANTUSIO NETO, R. - Occurrence of Cryptosporidium oocysts and Giardia cysts in raw water from the Atibaia river, Campinas, Brazil. Rev. Inst. Med. trop. S. Paulo, 43: 109-111, 2001. [ Links ]
14. GATEI, W.; GREENSILL, J.; ASHFORD, R.W. et al. - Molecular analysis of the 18S rRNA gene of Cryptosporidium parasites from patients with or without humam immunodeficiency virus infections living in Kenya, Malawi, Brazil, the United Kingdom, and Vietnam. J. clin. Microbiol., 41: 1458-1462, 2003. [ Links ]
15. GONÇALVES, E.M.N.; DA SILVA, A.J.; EDUARDO, M.B.P. et al. - Multilocus genotyping of Cryptosporidium hominis associated with diarrhea outbreak in a day care unit in São Paulo. Clinics, 61: 119-126. 2006. [ Links ]
16. JONES, J.L.; LOPEZ, A.; WAHLQUIST, S.P. et al. - Survey of clinical laboratory practices for parasitic diseases. Clin. infect. Dis., 38 (suppl 3): S198-S202, 2004. [ Links ]
17. MacKENZIE, W.R.; HOXIE, N.J.; PROCTOR, M.E. et al. - A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. New Engl. J. Med., 331: 161-167, 1994. [ Links ]
18. MATOS, O.; ALVES, M.; XIAO, L.; CAMA, V. & ANTUNES, F. - Cryptosporidium felis and C. meleagridis in persons with HIV, Portugal. Emerg. infect. Dis., 10: 2256-2257, 2004. [ Links ]
19. MEDEIROS, M.I.C.; NEME, S.N.; DA SILVA, P. et al. - Etiology of acute diarrhea among children in Ribeirão Preto - SP, Brasil. Rev. Inst. Med. trop. S. Paulo, 43: 21-24, 2001. [ Links ]
20. MONIS, P.T. & THOMPSON, R.C.A. - Cryptosporidium and Giardia zoonoses: fact or fiction? Infect. Genet. Evolut., 3: 233-244, 2003. [ Links ]
21. MUTHUSAMY, D.D.; RAO, S.S.; RAMANI, S. et al. - Multilocus genotyping of Cryptosporidium sp. isolates from human immunodeficiency virus-infected individuals in South India. J. clin. Microbiol., 44: 632-634, 2006. [ Links ]
22. PEDRAZA-DÍAZ, S.; AMAR, C.F.; McLAUCHLIN, J. et al. - Cryptosporidium meleagridis from humans: molecular analysis and description of affected patients. J. Infect., 42: 243-250, 2001. [ Links ]
23. PEDRAZA-DIAZ, S.; AMAR, C.; NICHOLS, G.L. & McLAUCHLIN, J. - Nested polymerase chain reaction for amplification of the Cryptosporidium oocyst wall protein gene. Emerg. infect. Dis., 7: 49-56, 2001. [ Links ]
24. PIENIAZEK, N.J.; BORNAY-LLINARES, F.J.; SLEMENDA, S.B. et al. - New Cryptosporidium genotypes in HIV-infected persons. Emerg. infect. Dis., 5: 444-449, 1999. [ Links ]
25. SAREDI, N. & BAVA, J. - Cryptosporidiosis in pediatric patients. Rev. Inst. Med. trop. S. Paulo, 40: 197-200, 1998. [ Links ]
26. SPANO, F.; PUTIGNANI, L.; McLAUCHLIN, J.; CASEMORE, D.P. & CRISANTI, A. - PCR-RFLP analysis of the Cryptosporidium oocyst wall protein (COWP) gene discriminates between C. wrairi and C. parvum, and between C. parvum isolates of human and animal origin. FEMS Microbiol. Lett.,150: 209-217, 1997. [ Links ]
27. SUNNOTEL, O.; LOWERY, C.J.; MOORE J.E. et al. - Cryptosporidium. Lett. appl .Microbiol., 43: 7-16, 2006. [ Links ]
28. TZIPORI, S. & WARD, H. - Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect., 4: 1047-1058, 2002. [ Links ]
29. XIAO, L.; BERN, C.; LIMOR, J. et al. - Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J. infect. Dis., 183: 492-497, 2001. [ Links ]
30. XIAO, L. & RYAN, U.M. - Cryptosporidiosis: an update in molecular epidemiology. Curr. Opin. infect. Dis., 17: 483-490, 2004. [ Links ]
Herminia Yohko Kanamura,
Instituto Básico de Biociências, Universidade de Taubaté,
Av. Tiradentes 500, 12030-180 Taubaté, SP, Brasil.
Received: 28 September 2007
Accepted: 21 February 2008